---
title: "Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the PhaseÂ 3 EVOLVE-MS-1 Study."
date: 2022-02-26
enddate:
---

Published in: *Advances in therapy*

DOI: [10.1007/s12325-022-02068-7](https://doi.org/10.1007/s12325-022-02068-7)

<img src="https://upload.wikimedia.org/wikipedia/commons/thumb/7/77/Open_Access_logo_PLoS_transparent.svg/800px-Open_Access_logo_PLoS_transparent.svg.png" alt="drawing" width="50" align="left"/> &nbsp;&nbsp;&nbsp;This publication is available in **Open Access**! (Hybrid OA)

&nbsp;&nbsp;&nbsp;<a href="https://link.springer.com/content/pdf/10.1007/s12325-022-02068-7.pdf">Access it freely here</a>

